Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
The prevalence of allergic rhinitis has increased in the past 30 years
and around 20-40% of the population is affected. The condition can
cause profound morbidity. On p 1624 Weiner et al report on a
systematic review of 16 randomised controlled trials comparing the
effectiveness of corticosteroids and oral H1 receptor antagonists (antihistamines) at relieving the symptoms of allergic rhinitis. Intranasal corticosteroids provided greater relief of nasal
blockage, discharge, and itch, and of postnasal drip, total nasal
symptoms, and global ratings than did antihistamines. Intranasal corticosteroids were also found to be more cost effective.